News & Events
Latest News
Dr. Richard Swartz Presents COVID-19 Research at International Dementia Symposium
Dr. Richard Swartz, ONDRI co-lead, will be presenting his research on the complex impacts of COVID-19 on stroke risk, care and outcomes
Past Events
Shaking things up: Virtual Dementia Care
Opportunities and Challenges from multiple Perspectives: *the Clinician, the Researcher, the Charity/Advocacy Organization* Free virtual public event Tuesday, June 22, 202110:00 – 11:00 AM EDT Dr. Sara Mitchell reviewed the literature and her personal experience with...
An Event to Honour Dr. Sandra Black
EVENT DETAILS Monday March 1, 2021 from 5:00 pm – 8:00 pm EST Dr. Black presented highlights from the Sunnybrook Dementia Study (1995 and still going strong!) Event was targeted to: Dr. Black’s colleagues & trainees (past and present) Patients & care partners...
ONDRI Study Community Engagement Event
On Tuesday February 9, 2021, the ONDRI team hosted an event designed to highlight relevant research findings and the launch of the new, cutting-edge HANDDS-ONT research study, including a technology ‘show & tell’ session. EVENT DETAILS Free virtual public...
All News
Eye tracking helps identify PD-like abnormalities in pre-PD individuals
ONDRI researchers have co-authored a paper highlighting promising new potential Parkinson’s Disease (PD) biomarkers (or early indicators of disease).
ONDRI@Home in the News: Waterloo researchers lead remote wearable technology program
Neurodegenerative disease research innovations through ONDRI@Home, based in Waterloo, Ontario, were featured in a news release.
ONDRI Featured in Dementia Dialogue Podcast
On March 9, 2021 Dementia Dialogue released the latest installment of its podcast entitled “Changing Roles in Dementia Research: From subjects to participants”. The episode features Jill Czuczman discussing her role as a care partner to her husband David, who is living with frontotemporal dementia, along with Dr. Rick Swartz, a stroke neurologist and ONDRI’s co-lead.
Congratulations to Susan Bronskill, PhD, for being promoted to the rank of Professor!
On behalf of the entire ONDRI team, we wanted to send out a hearty congratulations to Susan Bronskill, PhD. Dr. Bronskill who heads ONDRI’s Aim 4: Health Systems Research initiative, has been promoted to the rank of Professor at the Dalla Lana School of Public Health,...
ONDRI’s Richard Swartz, MD, PhD, Leads COVID-19 brain study using gaming technology
What does COVID-19 do to the brain? A team from Western University, the University of Toronto, and Sunnybrook Health Sciences Centre hope to answer this important question with a massive global study on the impacts of COVID on the brain. Instead of coming into a lab...
ONDRI Researchers Proud to Contribute to the 5th CCCDTD Guidelines
Since 1989, the Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTD) have provided evidence-based dementia guidelines for Canadian clinicians and researchers. As recently published in Alzheimer’s & Dementia, the journal of the...
ONDRI Supporting International Self-Care Day
Jill Czuczman, a member of ONDRI’s Patient & Community Advisory Committee, shares her experiences as a care partner to her husband who is living with Frontotemporal dementia. Clip is in support of International Self Help Day 2020.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the central nervous system
Read the scientific article co-written by ONDRI co-lead Doug Munoz, PhD, along with Fernanda G. De Felice, PhD. here.
Bill McIlroy, PhD: Aging Well Suzuki Style
Bill McIlroy, PhD, (ONDRI’s AIM 2 Lead & Gait Platform Co-Lead) was featured on an episode of David Suzuki’s Nature of Things. The episode titled “Aging Well Suzuki Style” highlights some of the assessments employed in ONDRI’s study protocols.
ONDRI & Partners Bring Important Public Health Messaging to Our Communities
Early in the COVID-19 pandemic, ONDRI brought a group of community advocacy groups together to generate relevant and tangible educational messages for people living with neurodegenerative disease, stroke and/or dementia.